EXTON, PA — Lungpacer Medical is set to make a significant impact at the ATS 2025 International Conference in San Francisco, where the company will present breakthroughs in interventional therapies aimed at improving outcomes for critically ill patients on mechanical ventilation.
Dr. Thiago Bassi, MD, PhD, senior research scientist at Lungpacer, will lead three pivotal presentations. On May 18 at 9:15 a.m. PT (poster board #811), Dr. Bassi will address the potential of phrenic nerve stimulation to restore respiratory drive and reduce brain injury biomarkers in acute respiratory distress syndrome (ARDS) patients.
On May 20 at 2:15 p.m. PT (poster board #502), preclinical findings in an ARDS model will reveal how diaphragm neurostimulation helps preserve kidney function and reduces related biomarkers of injury. The session will highlight encouraging results for future studies.
Finally, on May 21 at 11 a.m. PT, Dr. Bassi will join a panel examining ventilator-associated brain injury. Discussions will focus on how mechanical ventilation strategies influence the lungs-brain connection and how targeted management practices can enhance care for critically ill patients.
These presentations reflect Lungpacer Medical’s commitment to advancing intensive care practices and improving outcomes for some of the most vulnerable patients. By merging cutting-edge science with practical applications, the company is paving the way for enhanced treatment strategies in critical care.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.